Dysport gains US approval
30 April 2009
Alex Shimmings
Please Login to read the full article.
30 April 2009
Alex Shimmings
alex.shimmings@informa.com
The
US FDA has approved
Ipsen's botulinum neurotoxin type A product (abobotulinumtoxinA) under the single tradename Dysport for two indications, cervical dystonia and glabellar lines. The approvals have come just weeks after the filing missed its already-extended user fee date of April 13th due...
Please Login to read the full article.
RELATED CONTENT
NEWS
- European positive opinion for Allergan's Botox for neurogenic bladder incontinence
- Revance raises $45M for a needle-free wrinkle on botox market expansion
- Back to the clinic as Fox supports trial of NeuroHealing's drooling drug in Parkinson's
- Alexza blows up on FDA concerns over lung risks with inhaled antipsychotic
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
